Page last updated: 2024-10-31

mexiletine and Multiple Sclerosis

mexiletine has been researched along with Multiple Sclerosis in 2 studies

Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research Excerpts

ExcerptRelevanceReference
"Mexiletine was generally well tolerated with only two patients experiencing transient nausea and dizziness."5.28Mexiletine for thalamic pain syndrome. ( Awerbuch, GI; Sandyk, R, 1990)
"Mexiletine was generally well tolerated with only two patients experiencing transient nausea and dizziness."1.28Mexiletine for thalamic pain syndrome. ( Awerbuch, GI; Sandyk, R, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakurai, M1
Kanazawa, I1
Awerbuch, GI1
Sandyk, R1

Trials

1 trial available for mexiletine and Multiple Sclerosis

ArticleYear
Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine.
    Journal of the neurological sciences, 1999, Jan-15, Volume: 162, Issue:2

    Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Lidocaine; Male; Mexiletine; Middle Aged; M

1999

Other Studies

1 other study available for mexiletine and Multiple Sclerosis

ArticleYear
Mexiletine for thalamic pain syndrome.
    The International journal of neuroscience, 1990, Volume: 55, Issue:2-4

    Topics: Cerebral Hemorrhage; Cerebral Infarction; Female; Humans; Male; Mexiletine; Middle Aged; Multiple Sc

1990